Cargando…

B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple Sclerosis

BACKGROUND AND OBJECTIVES: To define the clinical and pathologic correlations of compartmentalized perivascular B cells in postmortem progressive multiple sclerosis (MS) brains. METHODS: Brain slices were acquired from 11 people with secondary progressive (SP) MS, 5 people with primary progressive (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moccia, Marcello, Haider, Lukas, Eshaghi, Arman, van de Pavert, Steven Harry Pieter, Brescia Morra, Vincenzo, Patel, Amy, Wheeler-Kingshott, Claudia Angela Michela, Barkhof, Frederik, Ciccarelli, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587731/ https://www.ncbi.nlm.nih.gov/pubmed/34759021 http://dx.doi.org/10.1212/NXI.0000000000001108

Ejemplares similares

Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes
por: Colato, Elisa, et al.
Publicado: (2021)

Spinal cord atrophy in a primary progressive multiple sclerosis trial: Improved sample size using GBSI
por: Moccia, Marcello, et al.
Publicado: (2020)

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
por: De Angelis, Marcello, et al.
Publicado: (2020)

Imaging outcome measures for progressive multiple sclerosis trials
por: Moccia, Marcello, et al.
Publicado: (2017)

Cortical involvement determines impairment 30 years after a clinically isolated syndrome
por: Haider, Lukas, et al.
Publicado: (2021)

Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review
por: De Angelis, Marcello, et al.
Publicado: (2021)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome
por: Sahi, Nitin, et al.
Publicado: (2023)

Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials
por: Moccia, Marcello, et al.
Publicado: (2020)

Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015
por: Moccia, Marcello, et al.
Publicado: (2017)

Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)
por: Moccia, Marcello, et al.
Publicado: (2020)

Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10
por: Moccia, Marcello, et al.
Publicado: (2019)

Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis
por: Petracca, Maria, et al.
Publicado: (2021)

Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis
por: Caliendo, Daniele, et al.
Publicado: (2023)

Deep gray matter volume loss drives disability worsening in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018)

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
por: Moccia, Marcello, et al.
Publicado: (2022)

Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study
por: Jonkman, Laura E., et al.
Publicado: (2015)

Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique
por: Tur, Carmen, et al.
Publicado: (2021)

JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
por: Lanzillo, Roberta, et al.
Publicado: (2014)

COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak
por: Buonomo, Antonio, et al.
Publicado: (2020)

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data
por: Moccia, Marcello, et al.
Publicado: (2021)

Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
por: Eshaghi, Arman, et al.
Publicado: (2021)

Author Correction: Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
por: Eshaghi, Arman, et al.
Publicado: (2021)

Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis
por: Li, Vivien, et al.
Publicado: (2022)

Linking immune-mediated damage to neurodegeneration in multiple sclerosis: could network-based MRI help?
por: Groppa, Sergiu, et al.
Publicado: (2021)

Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event
por: Collorone, Sara, et al.
Publicado: (2021)

Density of TMEM119-positive microglial cells in postmortem cerebrospinal fluid as a surrogate marker for assessing complex neuropathological processes in the CNS
por: Bohnert, Simone, et al.
Publicado: (2022)

Postmortem Tanning: An Unusual Postmortem Event
por: Weber, Brailyn, et al.
Publicado: (2023)

A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2022)

Corrigendum: A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2023)

Pre- and postmortem imaging of transplanted cells
por: Andrzejewska, Anna, et al.
Publicado: (2015)

Differences in topological progression profile among neurodegenerative diseases from imaging data
por: Garbarino, Sara, et al.
Publicado: (2019)

Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity
por: Freund, Patrick, et al.
Publicado: (2010)

Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2019)

A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple Sclerosis
por: Reia, Antonio, et al.
Publicado: (2021)

Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy
por: Moccia, Marcello, et al.
Publicado: (2022)

Determinants of early working impairments in multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2022)

DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
por: van de Pavert, Steven H P, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sh05enm8mcs5t7p7hjgd74msi1